• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cross-national differences in clinically significant cannabis problems: epidemiologic evidence from 'cannabis-only' smokers in the United States, Mexico, and Colombia.跨国家临床显著大麻问题差异:来自美国、墨西哥和哥伦比亚“只吸食大麻”人群的流行病学证据。
BMC Public Health. 2010 Mar 23;10:152. doi: 10.1186/1471-2458-10-152.
2
A comparison of drug use and dependence between blunt smokers and other cannabis users.吸食大麻烟者与其他大麻使用者之间药物使用及依赖情况的比较。
Subst Use Misuse. 2009;44(3):401-15. doi: 10.1080/10826080802347651.
3
[Drinking motivates, depending on the use of tobacco and cannabis among adolescents].[饮酒对青少年的影响取决于其烟草和大麻的使用情况]
Przegl Lek. 2014;71(11):592-6.
4
The epigenetic modulation of alcohol/ethanol and cannabis exposure/co-exposure during different stages.在不同阶段对酒精/乙醇和大麻暴露/共暴露进行表观遗传调节。
Open Biol. 2019 Jan 31;9(1):180115. doi: 10.1098/rsob.180115.
5
Cannabis use and co-use in tobacco smokers and non-smokers: prevalence and associations with mental health in a cross-sectional, nationally representative sample of adults in Great Britain, 2020.英国成年人 2020 年全国代表性横断面样本中,吸烟和不吸烟者中使用大麻和与烟草共用的情况:流行率以及与心理健康的关联。
Addiction. 2021 Aug;116(8):2209-2219. doi: 10.1111/add.15381. Epub 2021 Jan 22.
6
Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts.在被称为“钝器”的烟草-大麻混合使用者中,大麻问题体验情况。
Drug Alcohol Depend. 2015 May 1;150:77-84. doi: 10.1016/j.drugalcdep.2015.02.014. Epub 2015 Feb 23.
7
Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of tobacco and marijuana in adults from 2003-2012.评估烟草与大麻的重叠情况:2003年至2012年成年人中烟草与大麻共同使用模式的趋势
Addict Behav. 2015 Oct;49:26-32. doi: 10.1016/j.addbeh.2015.05.012. Epub 2015 May 23.
8
Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults.青少年和刚成年人群体在戒烟药物治疗试验中同时使用大麻和酒精。
Nicotine Tob Res. 2020 Jul 16;22(8):1374-1382. doi: 10.1093/ntr/ntz170.
9
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America.2002年至2010年欧洲和北美28个国家15岁青少年烟草和大麻同时使用的趋势。
Eur J Public Health. 2015 Apr;25 Suppl 2:73-5. doi: 10.1093/eurpub/ckv032.
10
Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis.澳大利亚人使用酒精、大麻和烟草情况:它们与其他药物使用及使用障碍、情感和焦虑障碍以及精神病之间关联的比较
Addiction. 2001 Nov;96(11):1603-14. doi: 10.1046/j.1360-0443.2001.961116037.x.

引用本文的文献

1
The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys.药物使用障碍的跨国流行病学:来自世界卫生组织世界心理健康调查的结果。
Int J Drug Policy. 2019 Sep;71:103-112. doi: 10.1016/j.drugpo.2019.03.002. Epub 2019 Jun 28.
2
Hookah Use Among College Students: Recent Use, Knowledge of Health Risks, Attitude and Reasons for Use.大学生水烟使用情况:近期使用情况、对健康风险的认知、态度和使用原因。
J Community Health. 2018 Dec;43(6):1037-1043. doi: 10.1007/s10900-018-0519-8.
3
Licit and illicit substance use patterns among university students in Germany using cluster analysis.采用聚类分析研究德国大学生的合法和非法物质使用模式。
Subst Abuse Treat Prev Policy. 2017 Oct 23;12(1):44. doi: 10.1186/s13011-017-0128-z.
4
Tobacco, marijuana, and alcohol use in university students: a cluster analysis.大学生中的烟草、大麻和酒精使用:聚类分析。
J Am Coll Health. 2012;60(5):374-86. doi: 10.1080/07448481.2012.663840.

本文引用的文献

1
Subtypes of nonmedical prescription drug misuse.非医疗用途处方药滥用的亚型。
Drug Alcohol Depend. 2009 Jun 1;102(1-3):63-70. doi: 10.1016/j.drugalcdep.2009.01.007. Epub 2009 Mar 10.
2
The Mexican migration to the United States and substance use in northern Mexico.墨西哥人向美国的移民以及墨西哥北部的物质使用情况。
Addiction. 2009 Apr;104(4):603-11. doi: 10.1111/j.1360-0443.2008.02491.x. Epub 2009 Feb 10.
3
Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys.关于酒精、烟草、大麻和可卡因使用的全球视角:世界卫生组织世界精神卫生调查的结果
PLoS Med. 2008 Jul 1;5(7):e141. doi: 10.1371/journal.pmed.0050141.
4
Assessment of cocaine and other drug dependence in the general population: "gated" versus "ungated" approaches.普通人群中可卡因及其他药物依赖的评估:“封闭式”与“开放式”方法
Drug Alcohol Depend. 2008 Mar 1;93(3):227-32. doi: 10.1016/j.drugalcdep.2007.09.024. Epub 2007 Dec 11.
5
Case ascertainment of alcohol dependence in general population surveys: 'gated' versus 'ungated' approaches.一般人群调查中酒精依赖的病例确诊:“封闭式”与“开放式”方法
Int J Methods Psychiatr Res. 2007;16(3):111-23. doi: 10.1002/mpr.220.
6
Assessing cannabis dependence in community surveys: methodological issues.在社区调查中评估大麻依赖:方法学问题。
Int J Methods Psychiatr Res. 2007;16(2):43-51. doi: 10.1002/mpr.206.
7
Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey.药物与酒精的同时使用:2000年全国酒精调查结果
Drug Alcohol Depend. 2007 Sep 6;90(1):72-80. doi: 10.1016/j.drugalcdep.2007.02.024. Epub 2007 Apr 18.
8
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.裸盖菇素可引发具有重大且持久的个人意义和精神意义的神秘主义类型体验。
Psychopharmacology (Berl). 2006 Aug;187(3):268-83; discussion 284-92. doi: 10.1007/s00213-006-0457-5. Epub 2006 Jul 7.
9
Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI).世界卫生组织(WHO)复合国际诊断访谈(WMHCIDI)的世界心理健康(WMH)版本中《精神疾病诊断与统计手册》第四版(DSM-IV)诊断的临床校准。
Int J Methods Psychiatr Res. 2004;13(2):122-39. doi: 10.1002/mpr.169.
10
The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).世界卫生组织(WHO)复合国际诊断访谈(CIDI)的世界心理健康(WMH)调查倡议版本。
Int J Methods Psychiatr Res. 2004;13(2):93-121. doi: 10.1002/mpr.168.

跨国家临床显著大麻问题差异:来自美国、墨西哥和哥伦比亚“只吸食大麻”人群的流行病学证据。

Cross-national differences in clinically significant cannabis problems: epidemiologic evidence from 'cannabis-only' smokers in the United States, Mexico, and Colombia.

机构信息

Department of Epidemiology, College of Human Medicine, Michigan State University, East Lansing, USA.

出版信息

BMC Public Health. 2010 Mar 23;10:152. doi: 10.1186/1471-2458-10-152.

DOI:10.1186/1471-2458-10-152
PMID:20331880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2863162/
Abstract

BACKGROUND

Epidemiological studies show wide variability in the occurrence of cannabis smoking and related disorders across countries. This study aims to estimate cross-national variation in cannabis users' experience of clinically significant cannabis-related problems in three countries of the Americas, with a focus on cannabis users who may have tried alcohol or tobacco, but who have not used cocaine, heroin, LSD, or other internationally regulated drugs.

METHODS

Data are from the World Mental Health Surveys Initiative and the National Latino and Asian American Study, with probability samples in Mexico (n = 4426), Colombia (n = 5,782) and the United States (USA; n = 8,228). The samples included 212 'cannabis only' users in Mexico, 260 in Colombia and 1,724 in the USA. Conditional GLM with GEE and 'exact' methods were used to estimate variation in the occurrence of clinically significant problems in cannabis only (CO) users across these surveyed populations.

RESULTS

The experience of cannabis-related problems was quite infrequent among CO users in these countries, with weighted frequencies ranging from 1% to 5% across survey populations, and with no appreciable cross-national variation in general. CO users in Colombia proved to be an exception. As compared to CO users in the USA, the Colombia smokers were more likely to have experienced cannabis-associated 'social problems' (odds ratio, OR = 3.0; 95% CI = 1.4, 6.3; p = 0.004) and 'legal problems' (OR = 9.7; 95% CI = 2.7, 35.2; p = 0.001).

CONCLUSIONS

This study's most remarkable finding may be the similarity in occurrence of cannabis-related problems in this cross-national comparison within the Americas. Wide cross-national variations in estimated population-level cumulative incidence of cannabis use disorders may be traced to large differences in cannabis smoking prevalence, rather than qualitative differences in cannabis experiences. More research is needed to identify conditions that might make cannabis-related social and legal problems more frequent in Colombia than in the USA.

摘要

背景

流行病学研究表明,各国之间大麻吸食和相关障碍的发生存在广泛差异。本研究旨在评估三个美洲国家的大麻使用者经历临床显著的大麻相关问题的跨国差异,重点关注那些可能尝试过酒精或烟草但未使用可卡因、海洛因、LSD 或其他国际管制药物的大麻使用者。

方法

数据来自世界心理健康调查倡议和国家拉丁裔和亚裔美国人研究,采用墨西哥(n=4426)、哥伦比亚(n=5782)和美国(n=8228)的概率样本。样本包括墨西哥的 212 名“仅大麻”使用者、哥伦比亚的 260 名和美国的 1724 名。采用条件广义线性模型和 GEE 以及“精确”方法来估计这些被调查人群中仅大麻使用者(CO)出现临床显著问题的发生率的变化。

结果

这些国家的 CO 使用者经历大麻相关问题的情况相当罕见,加权频率在不同调查人群中从 1%到 5%不等,且总体上没有明显的跨国差异。哥伦比亚的 CO 使用者是一个例外。与美国的 CO 使用者相比,哥伦比亚的吸烟者更有可能经历与大麻相关的“社会问题”(优势比,OR=3.0;95%置信区间,CI=1.4,6.3;p=0.004)和“法律问题”(OR=9.7;95%CI=2.7,35.2;p=0.001)。

结论

本研究最显著的发现可能是在美洲的跨国比较中,大麻相关问题的发生情况相似。大麻使用障碍的估计人群水平累积发生率的广泛跨国差异可能归因于大麻吸烟率的巨大差异,而不是大麻使用体验的质的差异。需要进一步研究以确定哪些条件可能使哥伦比亚的大麻相关社会和法律问题比美国更频繁。